These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24485042)

  • 1. Transaminase elevation secondary to the use of adalimumab.
    Juan-Guardela ML; Marín-Carrillo LF; Kattah-Martínez LX; Fernández-Ávila DG
    Reumatol Clin; 2014; 10(4):265-6. PubMed ID: 24485042
    [No Abstract]   [Full Text] [Related]  

  • 2. Sweet's syndrome in a patient affected by ankylosing spondylitis and ulcerative colitis under treatment with adalimumab.
    Bruscino N; Grandi V; Gunnella S; Maio V
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):195-6. PubMed ID: 25201185
    [No Abstract]   [Full Text] [Related]  

  • 3. Mania induced by adalimumab in a patient with ankylosing spondylitis.
    Ghossoub E; Habli M; Uthman I; Maalouf FT
    Int J Psychiatry Med; 2016 Aug; 51(6):486-493. PubMed ID: 28629289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple paradoxical adverse events in a patient with ankylosing spondylitis treated with adalimumab.
    Toussirot É; Charollais R; Aubin F
    Eur J Dermatol; 2016 Aug; 26(4):406-8. PubMed ID: 27099170
    [No Abstract]   [Full Text] [Related]  

  • 5. Search for a concentration-effect curve of adalimumab in ankylosing spondylitis patients.
    Marsman AF; Kneepkens EL; Ruwaard J; Wei JC; Nurmohamed MT; van Denderen C; van der Horst-Bruinsma IE; Rispens T; Wolbink G
    Scand J Rheumatol; 2016 Jul; 45(4):331-4. PubMed ID: 26727457
    [No Abstract]   [Full Text] [Related]  

  • 6. Synovial Leishmaniasis.
    Guidelli GM; De Stefano R; Galeazzi M; Selvi E
    Arthritis Rheumatol; 2016 Apr; 68(4):931. PubMed ID: 26663894
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequency of peripheral diseases in Korean patients with ankylosing spondylitis and the effectiveness of adalimumab.
    Lee SH; Park W; Won Lee S; Kim HA; Choe JY; Lee SH; Lee SS; Park SH; Park MC; Sheen DH; Lee HS; Lee YA; Lee Y; Kim TH
    Int J Rheum Dis; 2020 Aug; 23(9):1175-1183. PubMed ID: 32725789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An examination of the mechanisms involved in secondary clinical failure to adalimumab or etanercept in inflammatory arthropathies.
    Bandrés Ciga S; Salvatierra J; López-Sidro M; García-Sánchez A; Durán R; Vives F; Raya-Álvarez E
    J Clin Rheumatol; 2015 Apr; 21(3):115-9. PubMed ID: 25807089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Infliximab in Circulation for 7 Years?
    Kelting SM; Kimpel DL; Bruns DE
    Clin Chem; 2015 Nov; 61(11):1420-1. PubMed ID: 26511353
    [No Abstract]   [Full Text] [Related]  

  • 10. Early Adalimumab and Anti-Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients.
    Ding X; Zhu R; Wu J; Xue L; Gu M; Miao L
    Clin Transl Sci; 2020 May; 13(3):547-554. PubMed ID: 31961477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occurrence of vitiligo in a patient with ankylosing spondylitis receiving adalimumab].
    Toussirot E; Salard D; Algros MP; Aubin F
    Ann Dermatol Venereol; 2013 Dec; 140(12):801-2. PubMed ID: 24315228
    [No Abstract]   [Full Text] [Related]  

  • 12. [Miliary tuberculosis in a patient with morbus Bechterew treated with tumour necrosis factor-alpha].
    Lund-Andersen C; Grove M; Rasmussen K
    Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobular capillary hemangioma in a patient with ankylosing spondylitis using adalimumab: an exuberant presentation.
    Silva TS; Guimarães CLM; Xavier IP; Rego VRPA
    An Bras Dermatol; 2019; 94(6):751-753. PubMed ID: 31789263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed Drug Eruption to Biologics and Role of Lesional Patch Testing.
    Li PH; Watts TJ; Chung HY; Lau CS
    J Allergy Clin Immunol Pract; 2019; 7(7):2398-2399. PubMed ID: 31326380
    [No Abstract]   [Full Text] [Related]  

  • 15. Restoration of menstruation in premature ovarian failure after initiation of adalimumab.
    Aslanidis S; Pyrpasopoulou A; Douma S; Poulakos P; Triantafyllou A
    Scand J Rheumatol; 2008; 37(6):488-90. PubMed ID: 18752150
    [No Abstract]   [Full Text] [Related]  

  • 16. Adalimumab: new indication. Ankylosing spondylitis: just another TNF alpha antagonist. No comparisons with other TNF alpha antagonists.
    Prescrire Int; 2007 Oct; 16(91):193. PubMed ID: 17926830
    [No Abstract]   [Full Text] [Related]  

  • 17. Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis.
    Chen Z; Zheng X; Wu X; Wu J; Li X; Wei Q; Zhang X; Fang L; Jin O; Gu J
    Front Immunol; 2021; 12():700570. PubMed ID: 34539629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial.
    Huang F; Gu J; Zhu P; Bao C; Xu J; Xu H; Wu H; Wang G; Shi Q; Andhivarothai N; Anderson J; Pangan AL
    Ann Rheum Dis; 2014 Mar; 73(3):587-94. PubMed ID: 23475983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroparesis and ischemic gastric ulcers in a patient with rheumatoid arthritis receiving adalimumab therapy.
    Ngamruengphong S; Zhai Q; Francis DL
    Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):e35-6. PubMed ID: 25573493
    [No Abstract]   [Full Text] [Related]  

  • 20. Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.
    Davis JC; Revicki D; van der Heijde DM; Rentz AM; Wong RL; Kupper H; Luo MP
    Arthritis Rheum; 2007 Aug; 57(6):1050-7. PubMed ID: 17665483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.